Pet insurance provider Trupanion (NASDAQ: TRUP) announced better-than-expected revenue in Q2 CY2026, with sales up 11.1% year on year to $392.9 million. Its GAAP profit of $0.16 per share was 41.2% above analysts’ consensus estimates.
Is now the time to buy Trupanion? Find out by accessing our full research report, it’s free.
Trupanion (TRUP) Q2 CY2026 Highlights:
- Revenue: $392.9 million vs analyst estimates of $389.8 million (11.1% year-on-year growth, 0.8% beat)
- Pre-tax Profit: $7.37 million (1.9% margin)
- EPS (GAAP): $0.16 vs analyst estimates of $0.11 (41.2% beat)
- Market Capitalization: $1.08 billion
“We continue to execute on the priorities that matter most by growing margin, improving the economics of new enrollments, and investing our capital with discipline,” said Margi Tooth, Chief Executive Officer and President of Trupanion.
Company Overview
Born from a vision to help pet owners avoid economic euthanasia when faced with expensive veterinary bills, Trupanion (NASDAQ: TRUP) provides medical insurance for cats and dogs through data-driven, vertically-integrated products priced specifically for each pet's unique characteristics.
Revenue Growth
Insurance companies generate revenue three ways. The first is the core insurance business itself, represented in the income statement as premiums earned. The second source is investment income from investing the “float” (premiums collected but not yet paid out as claims) in assets such as fixed-income assets and equities. The third is fees from policy administration, annuities, and other value-added services. Over the last five years, Trupanion grew its revenue at an incredible 20.6% compounded annual growth rate. Its growth beat the average insurance company and shows its offerings resonate with customers.
Long-term growth is the most important, but within financials, a half-decade historical view may miss recent interest rate changes and market returns. Trupanion’s annualized revenue growth of 12.5% over the last two years is below its five-year trend, but we still think the results suggest healthy demand. 
This quarter, Trupanion reported year-on-year revenue growth of 11.1%, and its $392.9 million of revenue exceeded Wall Street’s estimates by 0.8%.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
Key Takeaways from Trupanion’s Q2 Results
It was good to see Trupanion beat analysts’ EPS expectations this quarter. We were also happy its revenue narrowly outperformed Wall Street’s estimates. Zooming out, we think this quarter featured some important positives. The stock traded up 5.2% to $25.66 immediately after reporting.
Trupanion had an encouraging quarter, but one earnings result doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. We think that the latest quarter is only one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).
